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We suggest that cerebral ischemia leads to ET, 5-HT, and ANG II receptor upregulation in the vascular smooth muscle cells via a mechanism that involves transcription and translation. We hypothesize that the molecular events in cerebral arteries correlate closely with the changes associated with the late cerebral ischemia as monitored with quantitative measurement of regional CBF. This was addressed by closely following the time course for the upregulation of the receptors involved in cerebral arteries and the regional and global CBF after SAH. We positively link these events to the pathophysiology of cerebral ischemia following SAH. Treatment with an inhibitor of the MAPK ERK1/2 abolished both upregulation and flow reduction (2) . There was a correlation between the upregulation of cerebrovascular receptors and the reduction in CBF.
MATERIALS AND METHODS
All animal procedures were carried out strictly within national laws and guidelines and were approved by the University Animal Experimentation Inspectorate.
Rat SAH Model
SAH was induced by a model carefully described by Prunell et al. (26) . Male Sprague-Dawley rats (350 -400 g) were anesthetized using 5% halothane (Halocarbon, River Edge, New Jersey) in 30% N 2O-70% O2. The rat was intubated and artificially ventilated with inhalation of 0.5-1.5% halothane in 30% N2O-70% O2 during the surgical procedure. The depth of anesthesia was carefully monitored, and the respiration was checked by regularly withdrawing arterial blood samples for blood gas analysis (Radiometer, Copenhagen, Denmark). An electric temperature probe was inserted into the rectum to record the temperature, which was maintained at 37°C. An arterial catheter to measure blood pressure was placed in the tail artery, and a catheter to monitor intracranial pressure (ICP) was placed in the subarachnoid space under the subocciptal membrane. At either side of the skull, 3 mm from the midline and 4 mm anterior of the bregma, holes were drilled through the scull bone down to the dura mater (without perforation), allowing the placement of two laser-Doppler flow probes to measure cortical CBF. Finally, a 27-gauge blunt canula with side hole was introduced stereotactically 6.5 mm anterior to the bregma in the midline at an angle of 30°to the vertical. With the aperture pointing to the right, the needle was lowered until the tip reached the scull base 2 to 3 mm anterior to the chiasma. After 30 min of equilibration, 250 l of blood were withdrawn from the tail catheter and injected intracranially at a pressure equal to the mean arterial blood pressure (MABP; 80 -100 mmHg). Subsequently, the rat was kept under anesthesia for another 60 min to allow recovery from the cerebral insult, after which catheters were removed and incisions closed. The rat was then revitalized and extubated. A subcutaneous injection of carprofen (4.0 mg/kg; Pfizer) was administered, and the rat was hydrated subcutaneously using 40 ml isotonic sodium chloride at the end of the operation. During the period of observation, the rat was monitored regularly, and if showing severe distress, the animal was prematurely euthanized. In addition, a series of sham-operated rats were prepared. They went through exactly the same procedure as described above with the exception that no blood was injected intracisternally (2, 3) . Two types of sham-operated rats were studied: no fluid injection or injection of saline (250 l) during 15 min to avoid any change in ICP. Both procedures revealed the same outcome. All surviving animals were neurologically examined using an established scoring system (1, 22) .
Harvest of Cerebral Arteries
After 0, 1, 3, 6, 12, 24, and 48 h of observation, the SAH and the control/sham-operated rats were anesthetized with CO 2 and decapitated. The brains were quickly removed and chilled in ice-cold bicarbonate buffer solution (see composition in In Vitro Pharmacology). Under a dissection microscope, the middle cerebral arteries (MCAs), the basilar artery (BA), and the circle of Willis were carefully dissected free from the brain and cleared of connective tissue. The vessel segments were immediately mounted in myographs for in vitro pharmacology or snap frozen at Ϫ80°C and examined by quantitative real-time PCR or immunohistochemistry.
In Vitro Pharmacology
For contractile experiments, a myograph was used for recording the isometric tension in isolated cerebral arteries (18, 23) . The vessels were cut into 1-mm-long cylindrical segments and mounted on two 40 m in diameter stainless steel wires in a Myograph (Danish Myo Technology A/S, Aarhus, Denmark). One wire was connected to a force displacement transducer attached to an analog-digital converter unit (ADInstruments, Oxford, UK). The other wire was connected to a micrometer screw, allowing fine adjustments of vascular tone by varying the distance between the wires. Measurements were recorded on a computer by use of a PowerLab unit (ADInstruments). The segments were immersed in a temperature-controlled buffer solution (37°C) of the following composition: (in mM) 119 NaCl, 15 NaHCO 3, 4.6 KCl, 1.2 MgCl 2, 1.2 NaH2PO4, 1.5 CaCl2, and 5.5 glucose. The buffer was continuously aerated with oxygen enriched with 5% CO 2 resulting in a pH of 7.4. The vessels were stretched to an initial resting tone of 2 mN and then allowed to stabilize at this tone for 1 h. The contractile capacity was determined by exposing the vessels to an isotonic solution containing 63.5 mM of K ϩ , obtained by partial change of NaCl for KCl in the above buffer. The contraction induced by K ϩ was used as a reference for the contractile capacity (18) . Only vessels responding by contraction of at least 2.0 mN to K ϩ for BA and 0.8 mN to K ϩ for MCA were included in the study. The presence of the endothelium was checked by precontracting the vessel using 5-HT (10 Ϫ6.5 M; Sigma, St. Louis, MO) and subsequently exposing the segments to carbachol (10 Ϫ5 M) (Sigma). A relaxant response by Ͼ50% of the precontracted tension was considered indicative of a functional endothelium (15) .
Concentration-response curves were obtained by cumulative application of 5-CT (Sigma) in the concentration range 10 Ϫ12 to 10 Ϫ5 M, ANG II (Sigma) in the concentration range 10 Ϫ12 to 10 Ϫ6 M, and ET-1 (AnaSpec, San Jose, CA) in the concentration range 10 Ϫ14 to 10 Ϫ7 M. Before the application of ANG II, the arteries were pretreated with the AT 2 receptor antagonist PD-123319 (10 Ϫ5.5 M) for 30 min (a kind gift from Dr. P. Morsing, Astra-Zeneca, Molndal, Sweden). ANG II response was investigated both with and without the AT 2 receptor antagonist PD-123319.
RNA Isolation
To quantify mRNA for the ETA, ETB, AT1, AT2, and 5-HT1B receptors, RT-PCR and real-time detection monitoring the PCR products were employed.
Total cellular RNA was extracted from BA, MCA, and circle of Willis using the TRIzol RNA isolation kit (Invitrogen) following the suppliers instructions. Briefly, the arteries were homogenized in 1 ml of TRIzol (Invitrogen) by using a TissueLyser (VWR). Subsequently, 200 l of chloroform were added, and the samples were incubated in room temperature for 3 min, followed by centrifugation at 15,000 g for 15 min at 4°C. The supernatant was collected and the organic phase discarded. Chloroform (200 l) was again added to remove all traces of phenol, and the samples were centrifuged at 15,000 g for 15 min at 4°C. The aqueous supernatant was again collected, and to precipitate the RNA, an equal amount of isopropanol was added and the samples were incubated overnight at Ϫ20°C.
Subsequently, the RNA was centrifuged at 15,000 g for 20 min at 4°C. The supernatant was discarded, and the resulting pellet was washed with 75% ethanol, air dried, and redissolved in diethylpyrocarbonatetreated water. Total RNA was determined using a GeneQuant Pro spectrophotometer measuring absorbance at 260-to-280 ratio (Amersham Pharmacia Biotech, Uppsala, Sweden).
Real-Time PCR
Reverse transcription of total RNA to cDNA was carried out using the Gene Amp RNA kit (Perkin-Elmer Applied Biosystems) in a Perkin-Elmer 2400 PCR machine at 42°C for 90 min and then 72°C for 10 min. The real-time quantitative PCR was performed with the GeneAmp SYBR Green PCR kit (PE Applied Biosystems) in a Perkin-Elmer real-time PCR machine (GeneAmp 5700 sequence detection system). The above synthesized cDNA was used as a template in a 25-l reaction volume, and a no template (a reagent control without added cDNA) was included in all experiments. The system automatically monitors the binding of a fluorescent dye to doublestrand DNA by real-time detection of the fluorescence during each cycle of PCR amplification. Specific primers for the rat ETA, ETB, AT1, AT2, and 5-HT1B receptor and housekeeping gene elongation factor-1 (EF-1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and ␤-actin were designed by using the Primer Express 2.0 software (PE Applied Biosystems) and synthesized by TAG Copenhagen A/S (Copenhagen, Denmark).
Receptor primers had the following sequences: ET A receptor forward: 5Ј-GTCGAGAGGTGGCAAAGACC-3Ј; ETA receptor reverse: 5Ј-ACAGGGCGAAGATGACAACC-3Ј; ETB receptor forward: 5Ј-GATAC-GACAACTTCCGCTCCA-3Ј; ETB receptor reverse: 5Ј-GTCCACGAT-GAGGACAATGAG-3Ј; 5-HT1B receptor forward: 5Ј-TCCGGGTCTC-CTGTGTACGT-3Ј; 5-HT1B receptor reverse: 5Ј-GGCGTCTGAGAC-TCGCACTT-3Ј; AT1 receptor forward: 5Ј-GGATGGTTCTCAGAGA-GAGTACAT-3Ј; AT1 receptor reverse: 5Ј-CCTGCCCTCTTGTACCT-GTTG-3Ј; AT2 receptor forward: 5Ј-TCTGTTAGTGGGATGCATGTA-ATCA-3Ј; and AT2 receptor forward reverse: 5Ј-TGTGGGCCTCCAAAC-CATT-3Ј.
The housekeeping gene EF-1, GAPDH, and ␤-actin were used as a reference, since they are continuously expressed to a constant amount in cells.
The housekeeping primers were designed as follows: EF-1 forward: 5Ј-GCAAGCCCATGTGTGTTGAA-3Ј; EF-1 reverse: 5Ј-TGATGA-CACCCACAGCAACTG-3Ј; GAPDH forward: 5Ј-GGCCTTCCGTGT-TCCTACC-3Ј; GAPDH reverse: 5Ј-CGGCATGTCAGATCCACAAC-3Ј; ␤-actin forward: 5Ј-GTAGCCATCCAGGCTGTGTTG-3Ј; and ␤-actin reverse: 5Ј-TGCCAGTGGTACGACCAGAG-3Ј.
The PCR reaction was carried out as follows: 50°C for 2 min, 95°C for 10 min, and the following 40 PCR cycles with 95°C for 15 s and 60°C for 1 min. Each sample was examined in duplicate. To verify that each primer pair only generated one PCR product at the expected size that a dissociation analysis was performed after each real-time PCR run. A blank control (without template) was used in all experiments. To prove that the cDNAs of EF-1, GAPDH, ␤-actin, AT 1, AT2, ETA, ETB, and 5-HT1B receptors were amplified with a similar efficacy during real-time PCR, a standard curve was made in which the C T values were plotted against cDNA concentration on the basis Ϫ1 log(concentration), where C T is the number of PCR cycles performed in one sample at a specific point of time and E is the amplification efficiency with an optimal value of one. Standard curves for ET A, ETB, AT1, AT2, 5-HT 1B, ␤-actin, GAPDH, and EF-1 were performed by dilution of cDNA sample (1:10, 1:100, and 1:1,000) (data not shown).
Immunohistochemistry
The MCA and BA were dissected out and then placed onto Tissue TEK (Gibco) and frozen. They were then sectioned into 10-m-thick slices. The primary antibodies used were rabbit anti-human ET B (IBL, 16207), diluted 1:400; goat anti-mouse 5-HT1B (sc-1461, Santa Cruz Biotechnologies), diluted 1:100; AT1 (sc-1173, Santa Cruz Biotechnologies), diluted 1:100; mouse anti-rat CD31 (MCA1746, Serotec), diluted 1:200; and mouse anti-rat smooth muscle actin (MCA1905T, Serotec), diluted 1:100. All dilutions were done in PBS with 10% fetal calf serum. The secondary antibodies used were donkey anti-mouse Cy5 conjugated (715-175-150, Jackson ImmunoResearch), 1:100; and donkey anti-rabbit Cy3 conjugated (711-165-152, Jackson ImmunoResearch), 1:100 in PBS with 10% fetal calf serum. The antibodies were detected at the appropriate wavelength in a confocal microscopy (Zeiss). As control, only secondary antibodies were used.
Autoradiographic Measurements of Regional CBF
Local CBF was measured by a model originally described by Sakurada et al. (30) and modified by Gjedde et al. (13) .
In brief, rats in the various groups (0, 24, and 48 h after SAH) were anesthetized using 5% halothane in 30% N 2O-70% O2. The animal was intubated and artificially ventilated with inhalation of 0.5 -1.5% halothane in 30% N 2O-70% O2 during the surgical procedure. The anesthesia and the respiration were monitored by regularly withdrawing arterial blood samples for blood gas analysis (Radiometer AS). A catheter to measure MABP was placed in the right femoral artery, and a catheter for blood sampling was placed in the left femoral artery. This catheter was connected to a constant velocity withdrawal pump (Harvard apparatus 22) for mechanical integration of tracer concentration. In addition, a catheter was inserted in one femoral vein for injection of heparin and for infusion of the radioactive tracer. The MABP was continuously monitored with a Powerlab Unit (ADInstruments). A temperature probe was inserted into the rectum of the rat to record the temperature, which was regularly maintained at 37°C. Elmer, Boston, MA) was given intravenously. Arterial blood (122 l) was withdrawn over 20 s. Immediately after this, the animal was decapitated, and the brain was removed and immersed in isopentane (J. T. Baker, Deventer, Netherlands) chilled to Ϫ50°C. The ␤-radioactivity scintillation counting was performed on the arterial blood samples with a program that included quench correction (Packard 2000 CA). The 14 C activity in the tissue was determined after sectioning the brain in 20-m sections at Ϫ20°C in a cryostat (Wild Leitz A/S, Glostrup, Denmark). The sections were exposed to X-ray films (Kodak) together with 14 C methylmethacrylate standards (Amersham Life Science) and exposed the films for 20 days. Densities of the autoradiograms were measured with a Macintosh computer equipped with an analog CF 4/1 camera (Kaiser, Germany) and a transparency flat viewer (Color-Control 5000, Weilheim, Germany). The 14 C content was determined in several brain regions (see Table 4 ). The CBF was calculated from the brain tissue 14 C activity determined by autoradiography using the equation of Gjedde et al. (13) .
Calculations and Statistics
Data are expressed as means Ϯ SE, and n refers to the number of rats. Statistical analyses were performed with Kruskal-Wallis nonparametric test with Dunn's post hoc test, where P Ͻ 0.05 was considered significant. The correlation analyses were performed with Spearman's rank correlation coefficient.
In vitro pharmacology. Contractile responses in each segment are expressed as percentages of the 63.5 mM K ϩ -induced contraction. Emax value represents the maximum contractile response elicited by an agonist, and the pEC50, the negative logarithm of the drug concentration that elicited half the maximum response. For biphasic responses, Emax 1 and pEC50 1 describe the high-affinity phase and Emax 2 and pEC50 2 describe the low-affinity phase.
Real-time PCR. Data were analyzed with the comparative cycle threshold (CT) method (16) . The relative amount of mRNA was calculated with the CT values of ETA, ETB, AT1, AT2, and 5-HT1B receptor mRNA in relation to the CT values of housekeeping genes mRNA in the sample by the formula X 0 /R 0 ϭ 2
CTR Ϫ CTR
, where X0 is the original amount of target mRNA, R0 is the original amount of housekeeping gene mRNA, CTR is the CT value for housekeeping gene and CTX is the CT value for the target. GAPDH, ␤-actin, and EF-1 were used as housekeeping genes. Each sample was examined in triplicate, and the mean was used. Results are presented as means Ϯ SE compared with 0 h, which was set to 100%.
Immunohistochemistry. The images were analyzed using the ImageJ software (http://rsb.info.nih.gov/ij/). The fluorescence in four to six different areas in each artery was measured, and a mean value was calculated. These values are presented as percent fluorescence in the SAH groups compared with the control group (0 h) or shamoperated group, where the control group is set to 100%.
RESULTS

SAH Model
The mortality rate of the animal model of SAH was 4%, and there was no difference in the mortality rate between the groups. The rats did not show any distressed behavior. All surviving animals were neurologically examined using an established scoring system (1, 22) . All SAH animals received a score of 1 and the sham-operated groups a score of 0. In all operated rats, mean arterial blood pressure (105 Ϯ 3 mmHg), PCO 2 (39 Ϯ 2 mmHg), PO 2 (108 Ϯ 4 mmHg), hematocrit (40 Ϯ 1 mmHg) values, and temperature were within acceptable limits during the operation. As a result of the blood being injected, the cortical blood flow dropped over both hemispheres to 18 Ϯ 3% of resting flow (there was no difference between the two laser-Doppler probe data), and the ICP increased from 9 Ϯ 1 to 120 Ϯ 11 mmHg. The laser-Doppler blood flow and the elevated ICP returned to the basal values within 1 h of postoperative monitoring.
In Vitro Pharmacology
K ϩ (63.5 mM) evoked contraction of the smooth muscle cells and was used as an internal control. K ϩ -induced contractions did not differ significantly between the vessels from the different groups (Tables 1-3 ; P ϭ 1.0). E max and pEC 50 values for respective group are presented in Tables 1-3 .
Contractile response to ET-1. The contractile response to ET-1 was concentration dependent. The contractile response to ET-1 was successively increased by time after SAH, reaching a maximum at 48 h (Fig. 1A and Table 1 ). Both MCA and BA from SAH at 48 h showed a leftward shift of the curve to ET-1. This indicates an enhanced contractile response to ET-1 compared with that in the control rats where a sigmoidal curve was obtained. The concentration-response relation to ET-1 in the BA is illustrated in Fig. 1A .
Contractile response to 5-CT. 5-CT gave raise to a biphasic concentration-dependent contraction both in MCA and BA, indicating the presence of two receptors, 5-HT 1B and 5-HT 2A , in a manner previously characterized in detail (17) . The contractile response to 5-CT successively increased with time, with a maximum at 48 h (Fig. 1B and Table 2 ), the BA is illustrated in the Fig. 1B .
Contractile response to ANG II. In MCA, ANG II (via AT 1 ) induced a concentration-dependent response that increased with time in contractile response (in the presence of the AT 2 receptor antagonist PD-123319). The contractile response to ANG II was successively increased with time, with a maximum at 24 h (Fig. 1C and Table 3 ). ANG II did not induce an increased contractility in the BA after SAH. In the absence of the AT 2 receptor antagonist PD-123319, there was no increased contractile response to ANG II with time (Fig. 1D) .
Real-Time PCR
The standard curves for each primer pair had almost similar slopes, demonstrating that EF-1, ␤-actin, GAPDH, ET A , ET B , AT 1 , AT 2 , and 5-HT 1B cDNA were amplified with the same efficiency (data not shown). In each PCR experiment, a notemplate control was included, and there were no signs of contaminating nucleic acids in those samples. Gene expression was normalized to the expression of three different housekeeping genes: ␤-actin, GAPDH, and EF-1. All the housekeeping genes gave the same results after normalization. Since the results from the three types of brain arteries were identical, the MCA, BA, and circle of Willis (n ϭ 5-9) were added together for the statistical analysis. The ET B , 5-HT 1B , and AT 1 receptor mRNA levels were elevated by time after SAH. The mRNA receptor levels for ET B showed a quick response to SAH with an initial transient peak at about 1 h and a maximum at the time point 24 h after SAH (Fig. 2A) . There was a significant increase in AT 1 receptor mRNA at 24 h (Fig. 2B) . The 5-HT 1B receptor mRNA level showed an initial peak at 12 h with a maximum response at 24 h after SAH (Fig. 2C) . The level of ET A (P ϭ 0.54) and AT 2 (P ϭ 0.51) receptor mRNA levels remained unchanged in SAH compared with the control group (data not shown).
Immunohistochemistry
Selective antibodies toward the ET B , 5-HT 1B , and AT 1 receptors visualized their smooth muscle cell localization using confocal microscopy. Double immunohistochemistry staining versus smooth muscle actin, expressed in the smooth muscle cells, and CD31, expressed in the endothelial cells, were performed to verify the localization. The immunohistochemistry experiments showed that the ET B , 5-HT 1B , and AT 1 receptor protein levels were elevated by time with a maximum at 48 h for the receptor subtypes (Fig. 3, A and B) . The ET B receptor protein level was elevated already at 3 h after SAH, whereas both the AT 1 and 5-HT 1B receptor protein levels increased at 6 h after SAH. The enhanced expression was localized to the smooth muscle cells. 
Regional Cerebral Blood Flow
There was a significant global decrease in CBF in the SAH group compared with the control from 134 Ϯ 7 to 53 Ϯ 3 ml⅐min Ϫ1 ⅐100 g Ϫ1 at 48 h after SAH. At the time point 24 h after SAH, the global CBF was 82 Ϯ 4 ml⅐min Ϫ1 ⅐100 g Ϫ1 (Fig. 4) . In addition, there was significantly lower blood flow at 48 h compared with 24 h. All the regions showed similar results, and there was no significant difference between the regions in their response to the SAH (Table 4) . Furthermore, as can be seen in the Table 4 , the CBF was successively reduced with the time after SAH.
Correlation Between Functional Data, mRNA and Protein Levels, and CBF
SAH induces a significant upregulation of ET B , 5-HT 1B , and AT 1 receptors in a time-dependent manner both at functional, mRNA, and protein levels. There is a difference in the time profile of the upregulation of the different receptors. The contractile ET B receptor appeared within the first 12-24 h after SAH, whereas both the AT 1 and 5-HT 1B receptors appeared between 24 to 48 h. The receptor mRNA expression revealed a maximum at 12-24 h for all receptor subtypes; however, the ET B receptor mRNA level showed an initial peak already at 1 h. The receptor protein expression revealed maximum at 24 -48 h after SAH. The functional contractile responses were parallel with the protein expression. These changes are parallel with a successive decrease in CBF (Fig. 5) . Thus there is a clear temporal correlation between the changes in receptor expression and reduction in CBF. This is illustrated for the ET B receptor (Fig. 5) , but it is similar for AT 1 and 5-HT 1B receptors (data not shown). A recalculation of the data in our previous study (2) revealed that a specific inhibitor of raf resulted in the normalization of both protein and function of ET B and 5-HT 1B receptors at the same time as the return of the CBF from 67 Ϯ 4 to 125 Ϯ 7 ml⅐min Ϫ1 ⅐100 g Ϫ1 .
DISCUSSION
The present study is the first to directly correlate the functional and protein expression of cerebrovascular smooth muscle receptors with the global and regional CBF after SAH. The receptor mRNA clearly preceded this event. Cerebral vasoconstriction is commonly seen after SAH due to the rupture of an intracranial aneurysm (40 -70%) and sometimes after head trauma (5-10%) and intracranial surgery. A considerable number of the affected subjects die as a cause of cerebral ischemia. The first angiographic association was provided by Ecker and Riemenschneider (9) (4, 36) . This pattern of events has been confirmed in experimental studies (25) . The relationship between the amount of subarachnoid blood and vasospasm is supported in both clinical and experimental studies (10, 11) . Svendgaard and colleagues (7, 26, 27) have in an elegant series of studies carefully analyzed the correlation between the amount of blood, angiographic vasoconstriction, CBF, and cerebral metabolism. By intracisternal Fig. 4 . Global cerebral blood flow (CBF) after induced SAH in rats. There is a reduction in the global CBF compared with that in control rats. Data were obtained by an autoradiographic method, and data are expressed as means Ϯ SE; n ϭ 6 rats in each group. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001. administration of 250 l of blood, a rodent model was created that replicates the major parts of the events that occur in human SAH (28) . By using this model, we have demonstrated that the late phase of cerebral ischemia is associated with de novo transcription of genes for contractile G protein-coupled receptors, for cytokines, and for inflammatory mediators (35) ; however, one missing piece of evidence is the relationship between late cerebral ischemia and cerebrovascular gene regulation. To address this crucial question, we have examined the detailed time course of SAH-induced upregulation of smooth muscle ET B , 5-HT 1B , and AT 1 receptors at both functional and molecular levels.
There is a difference in the time profile of the upregulation of the different receptors. The receptor mRNA expression revealed a maximum at 12-24 h for all receptor subtypes; however, the ET B receptor mRNA level showed an initial peak already at 1 h. The protein level for the ET B receptor increased at an earlier time point compared with the 5-HT 1B and AT 1. However, all three receptors showed a maximum at 48 h after SAH. The functional responses appeared later compared with mRNA and protein levels. The contractile ET B receptor appeared within the first 12-24 h after SAH, whereas both the AT 1 and 5-HT 1B receptors appeared between 24 to 48 h. The functional, mRNA, and protein levels for AT 1 receptors showed parallel results with a significant upregulation of the receptor at 24 h. Thus we have demonstrated a tight correlation between transcriptional activation of the ET B , 5-HT 1B , and AT 1 receptors genes and the contractile responses toward their respective receptor agonists. However, the mRNA expression was always earlier than protein and function. In addition, the ET B receptor had an earlier upregulation compared with the other receptors, which suggest a differentiated system of activation and, therefore, again, different signal transduction pathways for the upregulation of the respective receptors. Importantly, the contractile responses and the molecular changes were associated with a parallel reduction in CBF. This is in agreement with our hypothesis that an increase in cerebrovascular receptor expression results in an increase in vascular tone after SAH, which in turn causes late cerebral vasoconstriction and reduced cerebral blood flow with subsequent development of cerebral ischemia and neuronal death.
We have previously studied in detail the molecular mechanisms involved in the upregulation of receptors in brain vessels. We demonstrated that the upregulation of ET B receptors after organ culture is mediated via increased transcription and subsequent translation of receptor mRNA. The transcriptional blocker actinomycin D prevented the upregulated ET B receptor observed after organ culture in cerebral arteries both for function and mRNA, whereas the translational inhibitor cyclohexamide prevented only functional responses. In the present study we have examined both the mRNA, protein expression, and the functional responses to the respective receptor activation. Because they were all modified in SAH, it clearly suggests that there is an enhanced expression of the receptors in the cerebral vessels.
In a previous study with the same methodology, angiographic examinations of the cerebral arteries revealed a biphasic vasospasm with a maximal acute cerebral constriction at 10 min and a late maximal vasoconstriction at 2 days after the SAH (7). Here we have demonstrated that the maximum reduction in regional and global CBF appears at 48 h after SAH. In addition, the enhanced contractility toward the endogenous agonists appeared with a maximum at 48 h, except from AT 1 receptors. This suggests that the upregulation of cerebrovascular receptors and the reduction in CBF all correlate with the late vasoconstriction phase that occurs 48 h after SAH. In fact, plotting the functional data and molecular data in a correlation graph showed a significant correlation between function and protein expression. The response also correlates with the regional CBF in the present study. Further evidence for such a tight coupling between these events comes from our treatment studies; intracisternal administration of a MAPK ERK1/2 inhibitor (2) or a PKC inhibitor (3) resulted in loss of vascular ET B and 5-HT 1B receptor upregulation and prevention of CBF reduction after SAH.
We have demonstrated that SAH is not linked to a single specific receptor subtype, and this may therefore explain the partial therapeutic effects observed in many trials. In clinical studies, 5-HT antagonists have proven ineffective in relieving clinical vasospasm (37); however, this does not exclude the involvement of 5-HT receptors, since the antagonists used were nonspecific, but suggests a multifactor pathogenesis. Clinical trials with the selective ET A antagonist clazosentan have been performed. The results demonstrate that clazosentan reduces the severity of vasospasm following aneurysmal SAH; however, there was no positive effect in the outcome of the patients (34) . This supports our view that the inhibition of only one receptor system will not remedy other receptor systems involved. Instead, the mechanism responsible for the receptor upregulation might be a more promising target (2, 3) .
In conclusion, we have revealed that SAH induces an upregulation of ET B , 5-HT 1B , and AT 1 receptors, which occur in a time-dependent manner both at functional, mRNA, and protein levels. The protein expression changes are parallel with a successive decrease in CBF. Thus there is a close temporal correlate between the changes in receptor expression and the reduction in CBF.
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